BiotechTube

Anagre Cap.

ApprovedCompleted
0 views this week 0 watching⚡ Active
Interest: 43/100
43
Hype Score

Development Stage

✓
Pre-clinical
✓
Phase 1
✓
Phase 2
✓
Phase 3
5
Approved
Indication / Disease

Essential Thrombocythemia

Conditions

Essential Thrombocythemia

Trial Timeline

Jun 5, 2017 → Dec 5, 2020

NCT ID
NCT03232177

About Anagre Cap.

Anagre Cap. is a approved stage product being developed by Yuhan for Essential Thrombocythemia. The current trial status is completed. This product is registered under clinical trial identifier NCT03232177. Target conditions include Essential Thrombocythemia.

What happened to similar drugs?

14 of 20 similar drugs in Essential Thrombocythemia were approved

Approved (14) Terminated (2) Active (6)
✅Telmisartan/Amlodipine/Chlorthalidone 40/5/12.5 mg + Telmisartan/Amlodipine/Hydrochlorothiazide 40/5/25 mgYuhanApproved
✅olmesartan medoxomil + hydrochlorothiazide, if necessary + amlodipine, if necessaryDaiichi SankyoApproved
✅olmesartan medoxomil + hydrochlorothiazide, if necessary + amlodipine, if necessaryDaiichi SankyoApproved
✅Atenolol + olmesartan medoxomilDaiichi SankyoApproved
✅Arotinolol Hydrochloride + Metoprolol succinate sustained-release tabletSumitomo PharmaApproved
✅Aliskiren + Hydrochlorothiazide + AmlodipineNovartisApproved
✅Aliskiren + Ramipril + Matching placebo to Aliskiren + Matching placebo to RamiprilNovartisApproved

Hype Score Breakdown

Clinical
20
Activity
8
Company
15
Novelty
0
Community
0

Clinical Trials (1)

NCT IDPhaseStatus
NCT03232177ApprovedCompleted

Competing Products

20 competing products in Essential Thrombocythemia

See all competitors
ProductCompanyStageHype Score
L04RD1 + L04TD3CelltrionPhase 1
29
Azilsartan MedoxomilCelltrionPre-clinical
26
AZM X mg + AML Y mg + AZM X mg + AML Y' mg + AZM X' mg + AML Y mg + AZM X' mg + AML Y' mg + AZM X mg + AZM X' mg + AML Y mg + AML Y' mgCelltrionPhase 3
40
Telmisartan/Amlodipine/Chlorthalidone 40/5/12.5 mg + Telmisartan/Amlodipine/Hydrochlorothiazide 40/5/25 mgYuhanApproved
47
Telmisartan/Amlodipine/Chlorthalidone(Truset)YuhanPre-clinical
30
olmesartan medoxomil (OM)/hydrochlorothiazide (HCTZ) tablets and placebo + olmesartan medoxomil (OM)/hydrochlorothiazide (HCTZ) tablets + olmesartan medoxomil/hydrochlorothiazide tablets + olmesartan medoxomil/hydrochlorothiazide tabletsDaiichi SankyoPhase 3
40
olmesartan medoxomil + hydrochlorothiazide, if necessary + losartan + hydrochlorothiazide, if necessaryDaiichi SankyoPhase 3
40
CS8635 20/5/12.5mg and placebo + Olmetec® Plus 20/12.5mg and placeboDaiichi SankyoPhase 3
40
CS-3150 + olmesartan medoxomilDaiichi SankyoPre-clinical
26
olmesartan medoxomil + amlodipine + hydroclororthiazide + placebo + Olmesartan medoxomil + amlodipine + hydrochlorothiazide + placebo + olmesartan medoxomil + amlodipine + hydroclororthiazide + olmesartan medoxomil + amlodipine + hydroclororthiazide + olmesartan medoxomil + amlodipine + hydroclororthiazide + olmesartan medoxomil + amlodipine + olmesartan medoxomil + amlodipine + olmesartan medoxomil + amlodipineDaiichi SankyoPhase 3
40
Olmesartan medoxomil + Atenolol + Hydrochlorothiazide + olmesartan medoxomil + atenololDaiichi SankyoPhase 3
40
olmesartan medoxomil + hydrochlorothiazide, if necessary + amlodipine, if necessaryDaiichi SankyoApproved
43
CS-3150 + EplerenoneDaiichi SankyoPhase 3
40
olmesartan medoxomil + losartan potassiumDaiichi SankyoPhase 3
40
Olmesartan medoxomil 40 mg - Amlodipine 10 mg + Olmesartan 40mg-Amlodipine 10mg-Hydrochlorothiazide 12.5mg + Olmesartan 40mg-Amlodipine 10mg-Hydrochlorothiazide 25mg + OLM 40mg-AML 10mg-Hydrochlorothiazide 12.5mg + OLM 40mg-AML 10mg-Hydrochlorothiazide 12.5mg + OLM 40mg-AML 10mg-Hydrochlorothiazide 25mgDaiichi SankyoPhase 3
40
olmesartan medoxomil + hydrochlorothiazide, if necessary + amlodipine, if necessaryDaiichi SankyoApproved
43
Olmesartan medoxomil + Losartan + Furosemide oral tabletsDaiichi SankyoPhase 3
40
olmesartan medoxomil (OM)+ hydrochlorothiazide (HCTZ) tablets + olmesartan medoxomil (OM)/ hydrochlorothiazide (HCTZ) 20mg/25mgDaiichi SankyoPhase 3
40
olmesartan medoxomil + amlodipineDaiichi SankyoPhase 3
40
olmesartan medoxomil + amlodipine + hydrochlorothiazideDaiichi SankyoPhase 3
40